Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.3315
+0.0265 (8.69%)
At close: Aug 17, 2026, 4:00 PM EDT
0.3100
-0.0215 (-6.49%)
Pre-market: Aug 18, 2026, 4:26 AM EDT

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Xtant Medical Holdings stock has a consensus rating of "Buy" and an average price target of $1.05. The average 1-year stock price forecast is 216.74% higher than the current stock price, while the lowest is $0.60 (+81.00%) and the highest is $1.50 (+352.49%).

Price Target: $1.05 (+216.74%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$0.60$1.05$1.05$1.50
Change+81.00%+216.74%+216.74%+352.49%

Analyst Ratings

The average analyst rating for Xtant Medical Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingNov '25Dec '25Mar '26Apr '26May '26Jul '26
Strong Buy222221
Buy000011
Hold000000
Sell000000
Strong Sell000000
Total222232

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Buy
Reiterates
$1.2$0.6
BuyReiterates$1.2$0.6+81.00%Aug 12, 2026
Maxim Group
Maxim Group
Buy
Reiterates
$1.5
BuyReiterates$1.5+352.49%Aug 12, 2026
BTIG
BTIG
Buy
Maintains
$1.5$1
BuyMaintains$1.5$1+201.66%Apr 1, 2026

Financial Forecast

Revenue This Year
100.27M
from 133.93M
Decreased by -25.13%
Revenue Next Year
110.05M
from 100.27M
Increased by 9.76%
EPS This Year
-0.08
from 0.04
EPS Next Year
-0.04
from -0.08
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
55.26M57.97M91.30M117.27M133.93M100.27M
Revenue Growth
3.61%4.90%57.50%28.44%14.21%-25.13%
Gross Profit
32.49M32.14M55.47M68.22M84.27M60.06M
Gross Margin
58.79%55.44%60.75%58.17%62.92%59.90%
Operating Income
-3.25M-6.76M-10.16M-12.07M7.28M-14.67M
Net Income
-4.85M-8.49M660.00K-16.45M4.97M-16.17M
EPS
----0.04-0.08
Free Cash Flow
262.38K-4.20M-25.38M-9.47M6.50M-9.30M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High100.5M
Avg100.3M
Low100.0M

Revenue Growth

Revenue Growth202620272028
High
-24.9%
Avg
-25.1%
Low
-25.3%

EPS Forecast

EPS202620272028
High-0.08
Avg-0.08
Low-0.08

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-